首页> 外文期刊>Revista Brasileira de Anestesiologia >Eficácia do ondansetron e da alizaprida na preven??o de náusea e v?mito em laparoscopia ginecológica
【24h】

Eficácia do ondansetron e da alizaprida na preven??o de náusea e v?mito em laparoscopia ginecológica

机译:恩丹西酮和茜素对预防妇科腹腔镜恶心和呕吐的功效

获取原文
       

摘要

BACKGROUND AND OBJECTIVES: Gynecological laparoscopy is a procedure with a high incidence of postoperative nausea and vomiting (PONV). This study aimed at comparing the efficacy of ondansetron and alizapride in preventing PONV in patients submitted to gynecological laparoscopy. METHODS: Participated in this study 52 women physical status ASA I and II, aged 21 to 50 years, without previous gastric complaint, who were submitted to diagnostic or surgical laparoscopy. Patients were distributed in 2 groups: Group 1 - intravenous ondansetron (4 mg) and Group 2 - intravenous alizapride (50 mg), before anesthetic induction. All patients were premedicated with oral midazolam (7.5 mg), were induced with sufentanil (0,5 μg.kg-1) and propofol (2 mg.kg-1). Propofol (115 μg.kg-1) and N2O/O2 (FIO2 = 40%) were used for maintenance, and atracurium (0,5 mg.kg-1) was the neuromuscular blocker. Postoperative analgesia was achieved with cetoprofen (100 mg) and buscopam composto?. RESULTS: Both groups were identical in demographics and surgery and anesthesia duration. One Group 1 patient referred nausea. One Group 2 patients referred nausea and 3 referred vomiting, but results were not statistically significant. CONCLUSIONS: Ondansetron and alizapride were comparable in preventing PONV in patients submitted to gynecological laparoscopy.
机译:背景与目的:妇科腹腔镜检查是一种术后恶心,呕吐(PONV)发生率较高的手术。这项研究旨在比较恩丹西酮和茜素对预防妇科腹腔镜患者PONV的疗效。方法:参加本研究的52名ASA I和II型女性身体状况,年龄21至50岁,无先前胃部不适,均接受了诊断性或手术性腹腔镜检查。在麻醉诱导前,将患者分为2组:第1组-静脉使用恩丹西酮(4 mg)和第2组-静脉使用阿利哌利特(50 mg)。所有患者均接受口服咪达唑仑(7.5 mg)的预药治疗,舒芬太尼(0.5μg.kg-1)和异丙酚(2 mg.kg-1)诱导。丙泊酚(115μg.kg-1)和N2O / O2(FIO2 = 40%)用于维持,阿曲库铵(0.5 mg.kg-1)是神经肌肉阻滞剂。 cetoprofen(100 mg)和buscopam composto?可达到术后镇痛效果。结果:两组在人口统计学,手术和麻醉时间方面均相同。 1组1位患者转为恶心。 2组中有1例转为恶心,3例为呕吐,但结果无统计学意义。结论:在接受妇科腹腔镜检查的患者中,Ondansetron和alizapride在预防PONV方面具有可比性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号